Locations:
Search IconSearch
July 21, 2016/Cancer/News & Insight

Cancer Moonshot Plans and Priorities Becoming Clearer

National and local summits highlight needs

bolwell_650x450

In July, the Cancer Moonshot initiative organized national and local summits to discuss cancer research, treatment and prevention needs and the efforts being planned to address them.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Vice President Joe Biden, who heads the White House Moonshot program to accelerate the search for cures, assured summit participants that he’s good at “removing stuff,” meaning the bureaucratic red tape that can impede progress. The vice president also announced new public- and private-sector investments, policies, collaborations and other actions intended to help meet the Moonshot’s goal to make a decade of advances in cancer prevention, diagnosis, treatment and care in five years.

The latest developments are encouraging, writes Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, of Cleveland Clinic Cancer Center, who met Biden for a post-summit tour of Cleveland Clinic’s Langston Hughes Community Health and Education Center, which facilitates cancer prevention and screening.

Obstacles to cancer research and clinical trials, access to basic care in underserved communities and the soaring cost of cancer treatment are among the “stuff’ that the Moonshot program will need to tackle, Dr. Bolwell notes in a commentary for Fox News.

Read his full column here.

Photo Credit: ©Russell Lee

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad